The algorithm can be used to predict the histological score of a liver biopsy.

Transjugular Liver Biopsy: What to do if there is an Unfavorable Cavo-Hepatic Angle?

This advance could replace the very invasive liver biopsy.

Some patients should not have percutaneous liver biopsies.

Importantly, 45% of patients with no fibrosis on initial biopsy had progression.

A percutaneous liver biopsy was performed before and after 1 year of treatment.

Patients with PBC must have a consistent liver biopsy.

In case of chronic hepatitis, a PBH (liver biopsy puncture) is practiced to know the state of liver tissue: fibrosis, cirrhosis or cancer.

Liver biopsy is usually not needed unless the diagnosis is uncertain.

Liver biopsy is primarily carried out to evaluate uncertain liver diseases.

1- NAS score> = 4 on the basis of a histological analysis of a liver biopsy.

The examination costs almost 30 times less than a liver biopsy.

There is no evidence to support use of a liver biopsy to monitor hepatic toxicity in rheumatological indications.

There is no evidence to support use of a liver biopsy to monitor hepatic toxicity in rheumatological indications.

There is no evidence to support use of a liver biopsy to monitor hepatic toxicity in rheumatological indications.